Meningococcal Vaccines Market - 13% CAGR to 2020 Driven by Combination Vaccines and America

Aug 05, 2016, 04:00 ET from Sandler Research

PUNE, India, August 5, 2016 /PRNewswire/ --

The global meningococcal vaccines market 2016-2020 research report says availability of combination vaccines is one of the key trends aiding the growth of this market. Bacterial meningitis is caused by bacteria such as Haemophilus influenzae type B, meningococci, and pneumococci. Combination vaccines for meningitis target multiple causative agents, thereby preventing meningitis caused by these agents. Thus, combination vaccines eliminate the need to administer individual vaccines. The lower the number of injections administered, the lower the frequency of injection site reactions, such as pain, increasing patient compliance. Increased compliance results in effective prevention of the disease. Collectively, these factors decrease the development and marketing costs of the vaccine and increase the market revenue by effective prevention of the disease.

Complete report on meningococcal vaccines market spread across 68 pages, analyzing 3 major companies and providing 44 data exhibits now available at

The analysts forecast global meningococcal vaccines market to grow at a CAGR of 13.07% during the period 2016-2020. According to the 2016 meningococcal vaccines market report, the increase in awareness about vaccination and immunization programs will lead to the growth of this market. The WHO conducted a program in over 180 countries in 2013 under the slogan 'Protect your world - get vaccinated'. In 2015, the organization celebrated the European Immunization Week from April 22nd-26th. Every year, the last week of April is observed as the World Immunization Week as per the WHO mandate. In the US, the Association of American Physicians (AAP) and the National Institute of Agricultural Marketing (NIAM) helped increase vaccination coverage in the region. The Amanda Young Foundation is dedicated to reducing the number of deaths from meningococcal disease in Western Australia by organizing activities such as summits and fundraising events to raise awareness about the disease.

The meningococcal vaccines market growth is the inclusion of meningococcal vaccination in the National Immunisation Program (NIP) of various countries. The addition of meningococcal vaccine in NIP increases its accessibility for low-income families. Governments of various countries conduct routine immunization schedules to ensure the availability of these vaccines. During 2015, the Americas dominated the global meningococcal vaccines market with a market share of around 76%. Factors such as the growing consumption of meningococcal vaccines due to a high rate of incidence in the US coupled with the affordability of therapies owing to well-structured reimbursement plans are expected to further fuel growth in the meningococcal vaccine market in the Americas during the forecast period.

Global Meningococcal Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global meningococcal vaccines market for 2016-2020. To calculate the market size, the report considers the report considers the revenue generated from the sales of vaccines used to prevent meningococcal infections.

The following companies are the key players in the global meningococcal vaccines market: GSK, Sanofi, and Pfizer. Other prominent vendors in the market are Beijing Minhai Biotechnology, Bio Med, Hualan Biological Engineering, Imunoloski Zavod, JN International Medical, Nuron Biotech and Serum. Order a copy of Global Meningococcal Vaccines Market 2016-2020 report @

Another related report is Global H1N1 Vaccines Market 2016-2020, one trend that is boosting market growth is an improved understanding of immunology. Technological advances and improved understanding of immunology and immunotherapy have enabled the discovery of biomarkers. This has aided in developing therapy through natural body defense mechanisms. Therapeutic vaccines that are capable of inducing the immune system to attack the targeted diseased tissue with greater bioavailability and specificity and minimal side effects associated with therapeutic drugs are being developed. Browse complete report @

Explore other new reports on Pharmaceutical Market @ .

About Us: is your go-to source for all market research needs. Our database includes thousands of market research reports from over multiple leading global publishers & in-depth market research studies of over several micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441

Connect with Us: 
G+ / Google Plus:

SOURCE Sandler Research